Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients

Autor: Lorusso, D., Ferrandina, G., Greggi, S., Gadducci, A., Pignata, S., Tateo, S., Biamonte, R., Manzione, L., Di Vagno, G., Ferrau’, F., Scambia, G. *
Zdroj: In Annals of Oncology July 2003 14(7):1086-1093
Databáze: ScienceDirect